Business Description
Bioceltix SA
ISIN : PLBCLTX00019
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 25.92 | |||||
Equity-to-Asset | 0.66 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.02 | |||||
Piotroski F-Score | 3/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -73.4 | |||||
3-Year EPS without NRI Growth Rate | -54.4 | |||||
3-Year FCF Growth Rate | -96.2 | |||||
3-Year Book Growth Rate | 35.9 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 34.17 | |||||
9-Day RSI | 39.39 | |||||
14-Day RSI | 40.39 | |||||
6-1 Month Momentum % | -10.19 | |||||
12-1 Month Momentum % | 1.82 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 2.53 | |||||
Quick Ratio | 2.53 | |||||
Cash Ratio | 2.25 | |||||
Days Inventory | 2.79 | |||||
Days Payable | 521.45 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -7.9 | |||||
Shareholder Yield % | -6.93 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -148.93 | |||||
ROA % | -120.93 | |||||
ROIC % | -504.45 | |||||
ROC (Joel Greenblatt) % | -962.96 | |||||
ROCE % | -146.13 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 43.14 | |||||
Price-to-Tangible-Book | 43.03 | |||||
EV-to-EBIT | -17.29 | |||||
EV-to-EBITDA | -17.8 | |||||
EV-to-FCF | -19.43 | |||||
Price-to-Net-Current-Asset-Value | 58.92 | |||||
Price-to-Net-Cash | 72.67 | |||||
Earnings Yield (Greenblatt) % | -5.78 | |||||
FCF Yield % | -5.07 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Bioceltix SA Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil zł) | |||
EPS (TTM) (zł) | -3.74 | ||
Beta | 0 | ||
Volatility % | 46.86 | ||
14-Day RSI | 40.39 | ||
14-Day ATR (zł) | 2.775331 | ||
20-Day SMA (zł) | 67.075 | ||
12-1 Month Momentum % | 1.82 | ||
52-Week Range (zł) | 58.4 - 98 | ||
Shares Outstanding (Mil) | 4.13 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 3 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Bioceltix SA Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Bioceltix SA Stock Events
Event | Date | Price(zł) | ||
---|---|---|---|---|
No Event Data |
Bioceltix SA Frequently Asked Questions
What is Bioceltix SA(WAR:BCX)'s stock price today?
When is next earnings date of Bioceltix SA(WAR:BCX)?
Does Bioceltix SA(WAR:BCX) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |